Oncology
0 drugs are in development for Gastric Cancer (GC).
- Companies
- 0
- Clinical trials
- 5
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Gastric Cancer (GC) pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
About this indication
Gastric Cancer (GC) context
Oncology·MeSH: Stomach Neoplasms (D013274)
Narrower concept of MeSH descriptor Stomach Neoplasms
Prevalence
10.0 / 100K
Incidence
6.1 / 100K/yr
Frequently asked questions
How many clinical trials target Gastric Cancer (GC)?
There are 5 clinical trials targeting Gastric Cancer (GC) tracked by BioSniper.
What is the prevalence of Gastric Cancer (GC)?
The estimated prevalence of Gastric Cancer (GC) is approximately 10.0 per 100,000 population.